Article

Family history primary factor in development of AMD

Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, of the University of Wisconsin, Madison.

May 2 - Fort Lauderdale, FL - Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, of the University of Wisconsin, Madison.

A very important factor for the most common form of AMD is age. Most studies show an increase in severity and frequency of AMD lesions with age in patients 75 years of age and older compared with younger individuals.

Other risk factors, such as sex, blood pressure, and cigarette smoking, have been studied but the results are less definitive.

By far, the factor that has the strongest correlation with the development of AMD is family history, according to Dr. Klein. "It has become apparent that this familial risk is at least in part the result of genetic factors," she said at the annual meeting of the Association for Research in Vision and Ophthalmology.

Several investigators, she pointed out, have identified candidate regions in a variety of places in the genome. For example, in the Beaver Dam study, in which 602 families participated, analysis of the CFH gene locus is pending, but linkage has been to 1p35 and 15q22.

"The influence of any particular gene may be dependent on the effect of other genes and the environment. An approach that embraces personal and environmental factors and modifier genes is likely to be the most informative way to find out more about AMD," she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.